ABSTRACT The low density lipoprotein (LDL) receptor belongs to a class of migrant cell surface proteins that mediate endocytosis of macromolecular ligands. No cDNAs for this class of proteins have been isolated to date. In the current paper, we report the isolation of a cDNA clone for the LDL receptor from a bovine adrenal cDNA library. The library was constructed by the Okayama-Berg method from poly(A)V RNA that had been enriched in receptor mRNA by immunopurification of polysomes. Mixtures of synthetic oligonucleotides encoding the amino acid sequence of two neighboring regions of a single cyanogen bromide fragment were used as hybridization probes to identify a recombinant plasmid containing the LDL receptor cDNA. This plasmid, designated pLDLR-1, contains a 2.8-kilobase (kb) insert that includes a sequence which corresponds to the known amino acid sequence of a 36-residue cyanogen bromide fragment of the receptor. pLDLR-l hybridized to a mRNA of =5.5 The low density lipoprotein (LDL) receptor is a cell surface protein that plays a central role in the metabolism of cholesterol in humans and animals (1). Current interest in this protein arises from several distinguishing characteristics. First, since its discovery 10 years ago, it has proven to be a model system for the study of receptor-mediated endocytosis, a process by which macromolecules enter cells after binding to specific receptors in coated pits on the cell surface (2). Second, the cholesterol liberated by catabolism of the internalized LDL particle regulates, via a feedback mechanism, the rate of synthesis of both the LDL receptor and the rate-controlling enzyme of cholesterol biosynthesis, 3-hydroxy-3-methylglutaryl-CoA reductase (1). Third, the increased demand for cholesterol in certain steroidogenic tissues such as the adrenal cortex and the ovarian corpus luteum is met by an increased number of LDL receptors (3). A fourth, and foremost distinguishing feature of the LDL receptor, is that mutations affecting its structure and function give rise to one of the most prevalent human genetic diseases, familial hypercholesterolemia (1).
Okayama-Berg method from poly(A)V RNA that had been enriched in receptor mRNA by immunopurification of polysomes. Mixtures of synthetic oligonucleotides encoding the amino acid sequence of two neighboring regions of a single cyanogen bromide fragment were used as hybridization probes to identify a recombinant plasmid containing the LDL receptor cDNA. This plasmid, designated pLDLR-1, contains a 2.8-kilobase (kb) insert that includes a sequence which corresponds to the known amino acid sequence of a 36-residue cyanogen bromide fragment of the receptor. pLDLR-l hybridized to a mRNA of =5.5 kb in the bovine adrenal gland. This mRNA, like the receptor protein, was 9-fold more abundant in bovine adrenal than in bovine liver. pLDLR-1 cross-hybridized to a mRNA of =z5.5 kb in cultured human epidermoid carcinoma A-431 cells. This mRNA was markedly reduced in amount when sterols were added to the culture medium, an observation that explains the previously observed feedback regulation of LDL receptor protein. Southern The low density lipoprotein (LDL) receptor is a cell surface protein that plays a central role in the metabolism of cholesterol in humans and animals (1) . Current interest in this protein arises from several distinguishing characteristics. First, since its discovery 10 years ago, it has proven to be a model system for the study of receptor-mediated endocytosis, a process by which macromolecules enter cells after binding to specific receptors in coated pits on the cell surface (2) . Second, the cholesterol liberated by catabolism of the internalized LDL particle regulates, via a feedback mechanism, the rate of synthesis of both the LDL receptor and the rate-controlling enzyme of cholesterol biosynthesis, 3-hydroxy-3-methylglutaryl-CoA reductase (1) . Third, the increased demand for cholesterol in certain steroidogenic tissues such as the adrenal cortex and the ovarian corpus luteum is met by an increased number of LDL receptors (3) . A fourth, and foremost distinguishing feature of the LDL receptor, is that mutations affecting its structure and function give rise to one of the most prevalent human genetic diseases, familial hypercholesterolemia (1) .
The LDL receptor is a trace protein of cultured cells and animal tissues, constituting less than 0.01% of the total membrane protein (4, 5) . Recent advances have rendered feasible an approach to the molecular genetics of the receptor. Thus, the LDL receptor has been purified to homogeneity and shown to be an acidic glycoprotein with an apparent Mr of 160,000 (4) .
A partial amino acid sequence has been obtained (6) . Polyclonal (7, 8) and monoclonal (9) antibodies have been raised against the purified receptor and used to follow the biosynthesis and posttranslational processing of the protein in normal and mutant cells (5, 8) . In the current experiments, we have used these tools, together with recombinant DNA techniques, to isolate a cDNA for the bovine LDL receptor. METHODS Materials. Bovine tissue was frozen in liquid nitrogen within 5 min of slaughter. Adrenal glands were powdered in liquid nitrogen in a Waring blender and stored at -70°C prior to polysome isolation. A polyclonal antibody against the bovine adrenal LDL receptor was raised in rabbits and purified on staphylococcal protein A-Sepharose (8) . This antibody and its corresponding nonimmune rabbit IgG were free of gross RNase contamination as shown by their failure to alter the sedimentation behavior of polysomes on sucrose gradients. Human epidermoid carcinoma A-431 cells were grown in the absence or presence of sterols (25-hydroxycholesterol plus cholesterol) as described (10) . Oligonucleotides were synthesized by the phosphoramidite method (11) (1,000 A20 units) were clarified with a 10-min centrifugation at 20,000 X g, then diluted to 15 A260/ml in a buffer containing 25 mM Tris HCI at pH 7.5, 150 mM NaCl, 5 mM MgCi2, 0.1% Nonidet P-40, heparin at 0.2 mg/ml, and trichodermin at 1 ug/ ml and incubated with 6.25 mg of anti-receptor IgG or nonimmune IgG for 1 hr with stirring at 40C. The polysome/antibody slurry was then passed twice through a column of protein A-Sepharose (0.7 x 13 cm) equilibrated in the above dilution buffer at a flow rate of 8-10 ml/hr at 4°C. The column was washed overnight with 120 ml of dilution buffer. Bound polysomes were eluted at a maximal flow rate with 20 ml of 25 mM Tris HCI, pH 7.5/20 mM EDTA. The eluted fraction was heated 5 min at 65°C, brought to 0.5 M NaCI and 0.2% NaDodSO4, cooled to 240C, and passed through a column of oligo(dT)-cellulose (0.8 x 2.3 cm) equilibrated in 10 mM Tris HCl, pH 7.5/ 0.5 M NaCl. The column was washed with 20 ml of this buffer and poly(A)+ RNA was eluted with 5 ml of 10 mM Tris HCI, pH 7.5. Yeast carrier tRNA (50 jig) was added, and the RNA was precipitated twice with NaOAc and ethanol. This immunopurified poly(A)+ RNA was resuspended in 20,ul of water and stored at -700C.
In Vitro Translation. Aliquots of poly(A)+ mRNA were incub'ated with 2.5 mM CH3HgOH for 10 min at 4°C and then translated in rabbit reticulocyte lysates prepared as described by Pelham and Jackson (17) and supplemented with 80 mM KOAc, 1 mM Mg(OAc)2, 19 amino acids (excluding methionine) at 16 MuM each, and [35S]methionine at 0.2 mCi/ml (1 Ci = 3.7 X 1010 Bq). The final concentration of CH3HgOH in the translation reaction was 0.3 mM. Translation products were analyzed by electrophoresis on NaDodSO4/7% polyacrylamide gels.
cDNA Cloning. A cDNA library was constructed by the method of Okayama and Berg (12) from immunoselected poly-(A)' RNA derived from 2,000 A260 units of polysomes. In the cloning reactions, which employed enzymes obtained from Life Sciences and P-L Biochemicals, 1.4 jig of dT-tailed vector primer and 0.52 pmol of dG-tailed linker were used.
Identification of LDL Receptor cDNA Clones. Portions of the cDNA library were used to transform Escherichia coli RR1 to ampicillin resistance by the CaCl2-shock procedure (ref. 18 , p. 250). Colonies were plated at-high density on nitrocellulose filters, and two replica filters were prepared for hybridization (ref. 18 , p. 316). To reduce nonspecific background, baked filters were washed overnight in 50 mM Tris HCl, pH 8/1 mM EDTA/1 M NaCl/0. 1% NaDodSO4 at 37 or 42°C and then incubated at 659C for 3 hr in 4X NaCl/Cit (1 x NaCl/Cit = 0.15 M NaCI/15 mM sodium citrate), lOx Denhardt's solution (ref. 18 , p. 327), and sonicated and denatured E. coli DNA at 100 Mug/ml. Hybridization was performed overnight in the latter solution containing 32P-5'-end-labeled oligonucleotide mixtures (6 X 106 cpm/pmol) at 1 pmol/ml. Hybridization temperature for a given oligonucleotide probe corresponded to the minimum melting temperature, tm, calculated from the empirical formula tm = 20C(no. of dAdT bp) + 40C(no. of dGdC bp), in which bp is base pairs (19) . Filters were washed three times in 4x NaCI/Cit at the hybridization temperature for 30 min per wash, dried at room temperature, and subjected to autoradiography. Positive clones were picked from the master plate and purified through several rounds of screening. Bacteriophage M13 cloning and sequencing procedures were as described (20) (21) (22) .
Blot Hybridization of Poly(A)+ RNA. Total RNA was isolated from the indicated source by treatment of tissues or cells with guanidinium thiocyanate (ref. 18, p. 196) . Poly(A)+ RNA was purified by oligo(dT)-cellulose chromatography, denatured with glyoxal, size-fractionated by electrophoresis (20 V, 16 hr) on 1.5% agarose gels containing 40 mM 3-N-morpholinopropanesulfonic acid (pH 7.0), and then transferred to Zeta Probe membranes (Bio-Rad) by capillary blotting in 20x NaCI/Cit. Prehybridization and hybridization were carried out as described (ref. 18, p. 326) .
Blot Hybridization of DNA. DNA was isolated from bovine liver (ref. 18 , p. 281), digested to completion with restriction enzymes, size-fractionated by agarose gel electrophoresis, and analyzed by the method of Southern (23) .
RESULTS
The strategy employed in cloning the LDL receptor cDNA is outlined in Fig. 1 . The individual steps in the isolation and characterization of the cDNA were as follows:
Preparation of Two Oligonucleotide Families Corresponding to Amino Acid Sequence of LDL Receptor. The purified LDL receptor was digested with CNBr, an internal CNBr fragment was isolated by HPLC, and its partial amino acid sequence was determined by automated Edman degradation. Two families of synthetic oligonucleotide probes that corresponded to all possible codons specifying the sequence of amino acids in two neighboring regions of this CNBr fragment were synthesized. One family of oligonucleotides, designated A in Fig.  1 The immunoselected poly(A)+ RNA was assayed for the presence of LDL receptor mRNA by in vitro translation in a reticulocyte lysate system (Fig. 2) . Total adrenal gland poly(A)+ RNA directed the synthesis of many proteins, as determined by NaDodSO4 gel electrophoresis and fluorography of the synthesized products (lane 2). Poly(A)+ RNA derived from the immunopurified polysomes directed synthesis of several of the same protein bands plus one clear addition: a protein that migrated with a Mr of -120,000 (arrow, lane 3). This protein was not demonstrable after translation of poly(A)+ RNA selected from polysomes with nonimmune IgG (lane 4). Biosynthetic studies on the LDL receptor from humans (5), hamsters (24) , and rabbits (25) (Fig. 1) , and 30 cDNA clones were identified. When these clones were probed separately with the subfamilies B or B*, 16 clones hybridized strongly with oligonucleotide mixture B. but not with B*. Twelve of the 30 clones were positive only with mixture B*. These 28 positive clones were then screened with oligonucleotide mixture A, and two plasmids, both from the latter group of 12, hybridized with this probe. These two clones were considered to contain cDNAs for the receptor and were chosen for further study.
Plasmid DNAs from the two clones that hybridized to both the B* and A oligonucleotide probes were subjected to restriction endonuclease mapping, and the results indicated that these two clones were identical. A partial restriction map for the 2.8-kb cDNA insert in these plasmids, designated pLDLR-1, is shown in Fig. 3A . Southern blotting experiments in which oligonucleotide mixtures A and B* were used as probes indicated that both of these sequences were present in a 432-bp Pst I fragment located at the 5' end of the cDNA insert (Fig. 3A) . This fragment was isolated from pLDLR-1 and cloned in both orientations in the bacteriophage M13 mp8 vector (26) .
Before proceeding further with pLDLR-1, we sought to confirm the homology with the oligonucleotide probes by determining the sequence of the relevant portion of the 432-bp Pst I fragment. However, obtaining a nucleotide sequence of this fragment in the region of oligonucleotide homology turned out to be difficult and required a novel approach. Preliminary sequence analysis of the M13 clones by using a universal primer suggested that the homologous sequences were located in the center of this fragment in regions of the sequencing gel that were difficult to read unambiguously, possibly due to the high G+C content of this DNA fragment. In an attempt to circumvent this problem, we used oligonucleotide mixture B* as a primer for dideoxynucleotide sequencing, using labeled nucleotides and the appropriate M13 clone. The autoradiograms generated in these experiments were unreadable, indicating that priming was occurring in more than one location on the M13 clone. In a final, successful, effort to obtain the sequence, Pst I and denatured, and the mixture was run on a 7 M urea/ polyacrylamide gel. A radiolabeled fragment =240 bp long was isolated and subjected to chemical sequence analysis (22) . The results revealed the nucleotide sequence upstream of the oligonucleotide B* homology; this sequence included a region of DNA precisely complementary to one of the components of the A oligonucleotide mixture. Fig. 3 shows the sequence of a 108-bp portion of the cDNA in the region of complementarity to the A and B* oligonucleotides. This DNA sequence was derived from a combination of the strategies described above. It encodes, in one of the three Biochemistry: RusseU et al. In the observed protein sequence, the amino acids in parentheses indicate tentative assignments based on data obtained in only one of the two sequenator runs. Dashes in the observed protein sequence correspond to amino acid residues whose identity was not determined in either of the sequenator runs. The circled methionine was inferred on the basis of the preference of CNBr to cleave after this residue.
possible reading frames, a protein sequence of 36 amino acids that agrees with one exception with that determined from the CNBr peptide (see Discussion). The correspondence of nucleotide and amino acid sequence was interpreted as strong evidence that pLDLR-1 contained a cDNA for the bovine LDL RNA Analysis by Blot Hybridization with pLDLR-1. To confirm the identity of pLDLR-1, total poly(A)+ RNA was extracted from bovine adrenal glands and liver and analyzed in blotting experiments using nick-translated 32P-labeled plasmid as a probe (Fig. 4) . Increasing amounts of adrenal gland RNA (lanes 1 and 2) yielded a progressively stronger hybridization signal corresponding to a mRNA of '=5.5 kb. Densitometric scanning showed that the signal obtained with a given amount of adrenal RNA was 9-fold more intense than that obtained with the same amount of liver RNA (lanes 3 and 4). Previous studies have shown that functional LDL receptor activity is about one order of magnitude more abundant in bovine adrenal than in bovine liver (3), a finding that coincides with the difference in the abundance of the mRNAs detected in Fig. 4 .
The number of LDL receptors can be markedly reduced when cultured cells are grown in the presence of cholesterol or related sterols (1, 10) . Poly(A)+ RNA was isolated from human A-431 cells grown in the absence of sterols (receptor-induced) and presence of sterols (receptor-suppressed) and analyzed by blotting with pLDLR-1 (Fig. 4) . A strong hybridization signal from a mRNA of ==5.5 kb was detected in the induced RNA (lane 5), and this signal was reduced by more than 90% in the suppressed RNA (lane 6). When this same blot was reprobed with a 32P-labeled plasmid containing a chicken actin cDNA insert of 1.8 kb, a signal corresponding to actin mRNA was detected in all lanes. Specifically, the intensities of the signal for actin mRNA in lanes 5 and 6 were identical (data not shown).
Analysis of Bovine DNA by Blot Hybridization with pLDLR-1. DNA was isolated from bovine liver, digested with restriction endonucleases, and analyzed by the method of Southern (23) . Digestion of the DNA with EcoRI, Xba I, Pst I, BamHI, and HindIII (lanes 1-5, respectively, in Fig. 5 tion with 32P-labeled pLDLR-1 yielded results consistent with the presence of a single-copy gene containing introns.
DISCUSSION
Using a combination of polysome immunopurification and ohgonucleotide hybridization (Fig. 1) , we have isolated a cDNA clone (pLDLR-1) for the bovine LDL receptor. Several lines of evidence support this conclusion. The nucleotide sequence of a region of the cDNA insert in pLDLR-1 encodes, with the exception of one amino acid, a protein sequence identical to that obtained from a CNBr fragment of the LDL receptor (Fig.  3) . This 108-bp nucleotide sequence encodes 26 amino acid residues that were not represented in the two families of oligonucleotides used as hybridization probes to select the cDNA. In one position of the amino acid sequence, an Ala residue was observed on a single sequenator run, whereas the DNA sequence predicts an Asn. This discrepancy may either be technical or due to polymorphism in the LDL receptor gene of different animals.
RNA blotting analysis was used to confirm the identity of pLDLR-1 (Fig. 4) . When this plasmid was used as a probe, a mRNA of approximately 5.5 kb was detected in the bovine adrenal gland. This RNA was about 9-fold more abundant in the adrenal gland than in the liver, a result that agrees well with the relative number of LDL receptors in these two tissues (3) . When the bovine cDNA was hybridized to RNA isolated from human A-431 cells, a mRNA of approximately 5.5 kb was detected in cells grown in the absence of sterols (receptor-induced). The amount of this mRNA was reduced by more than 90% when the human cells were grown in the presence of sterols to repress the synthesis of LDL receptors.
Several conclusions may be drawn from the RNA blotting results. First, the 2.8-kb cDNA insert in pLDLR-1 represents approximately one-half of the 5.5-kb bovine LDL receptor mRNA. Second, the bovine cDNA cross-hybridizes with a similar-sized mRNA in human A-431 cells. Third, the previously observed suppression of LDL receptor activity in cultured cells grown in the presence of sterols (sometimes termed "down regulation") can now be attributed to a reduction in the mRNA level.
The LDL receptor is one member of a class of cell surface proteins that bind ligands, carry them into cells via coated pits, and thereafter return to the surface (2, 27) . Many of these receptors, like the LDL receptor, are subjected to down regulation. The current findings suggest that one mechanism for receptor down regulation in general may involve feedback regulation of the mRNA for the receptor. The availability of a cDNA probe to the LDL receptor should allow other questions to be answered regarding the structure, mechanism of action, and genetics of this important class of cell surface proteins. The ability of the bovine cDNA to cross-hybridize with the human mRNA should allow the isolation of the human gene, and hence dissection of the molecular events giving rise to the prevalent genetic disease familial hypercholesterolemia. Finally, inasmuch as the bovine cDNA cross-hybridizes with the rabbit LDL receptor mRNA (data not shown), it should be possible to isolate the rabbit gene for use in characterizing the molecular lesion in the WHHL rabbit, an animal counterpart of familial hypercholesterolemia (28) .
